217 related articles for article (PubMed ID: 7929414)
1. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.
Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413
[TBL] [Abstract][Full Text] [Related]
3. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.
Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE
J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.
Schultz-Cherry S; Murphy-Ullrich JE
J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738
[TBL] [Abstract][Full Text] [Related]
5. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.
Tolsma SS; Volpert OV; Good DJ; Frazier WA; Polverini PJ; Bouck N
J Cell Biol; 1993 Jul; 122(2):497-511. PubMed ID: 7686555
[TBL] [Abstract][Full Text] [Related]
6. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
Adams JC; Lawler J
Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
[TBL] [Abstract][Full Text] [Related]
7. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.
Guo N; Krutzsch HC; Inman JK; Roberts DD
Cancer Res; 1997 May; 57(9):1735-42. PubMed ID: 9135017
[TBL] [Abstract][Full Text] [Related]
9. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
[TBL] [Abstract][Full Text] [Related]
10. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
Young GD; Murphy-Ullrich JE
J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
[TBL] [Abstract][Full Text] [Related]
11. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
Taraboletti G; Belotti D; Borsotti P; Vergani V; Rusnati M; Presta M; Giavazzi R
Cell Growth Differ; 1997 Apr; 8(4):471-9. PubMed ID: 9101093
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
Murphy-Ullrich JE; Gurusiddappa S; Frazier WA; Höök M
J Biol Chem; 1993 Dec; 268(35):26784-9. PubMed ID: 8253815
[TBL] [Abstract][Full Text] [Related]
14. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta complexes with thrombospondin.
Murphy-Ullrich JE; Schultz-Cherry S; Höök M
Mol Biol Cell; 1992 Feb; 3(2):181-8. PubMed ID: 1550960
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium.
Souchelnitskiy S; Chambaz EM; Feige JJ
Endocrinology; 1995 Nov; 136(11):5118-26. PubMed ID: 7588249
[TBL] [Abstract][Full Text] [Related]
17. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation.
Sakamoto Y; Miyazaki A; Tamagawa H; Wang GP; Horiuchi S
Atherosclerosis; 2005 Nov; 183(1):85-93. PubMed ID: 15907858
[TBL] [Abstract][Full Text] [Related]
18. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide.
Abe M; Oda N; Sato Y; Shibata K; Yamasaki M
Endothelium; 2002; 9(1):25-36. PubMed ID: 12901358
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
